CD4 and immunodeficiency disease: Adherence to guidelines was poorer in treatment of mild immunodeficiency (200–350 CD4 cells/mm3) which physicians may have considered less urgent than the treatment of more advanced immunodeficiency (CD4<200 cells/mm3).